Imeglimin, unlike metformin, does not perturb differentiation of human induced pluripotent stem cells towards pancreatic β‐like cells and rather enhances gain in β cell identity gene sets.
Saved in:
| Title: | Imeglimin, unlike metformin, does not perturb differentiation of human induced pluripotent stem cells towards pancreatic β‐like cells and rather enhances gain in β cell identity gene sets. |
|---|---|
| Authors: | Imada, Tasuku1 (AUTHOR), Sasaki, Shugo1 (AUTHOR) shugosasaki@endmet.med.osaka-u.ac.jp, Yamaguchi, Hiroki1 (AUTHOR), Ueda, Ayaka1 (AUTHOR), Kawamori, Dan1,2,3 (AUTHOR), Katakami, Naoto1 (AUTHOR), Shimomura, Iichiro1 (AUTHOR) |
| Source: | Journal of Diabetes Investigation. Apr2025, Vol. 16 Issue 4, p584-597. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
